# EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.

> **NCT05131776** · PHASE2,PHASE3 · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 2 (actual)

## Conditions studied

- Pancreatic Cancer
- Endoscopic Ultrasound

## Interventions

- **DEVICE:** EUS-guided oncosil injection

## Key facts

- **NCT ID:** NCT05131776
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Inadequate funding
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05131776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05131776, "EUS-guided Intra-tumour Injection of OncoSil for Locally Advanced Pancreatic Carcinoma.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05131776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*